Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2

Author(s):  Giacoia George P, Taylor-Zapata Perdita, Mattison Donald

Issue:  May/Jun 2007 - Pain Management
View All Articles in Issue

Page(s):  220-225

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 1
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 2
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 3
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 4
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 5
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 6

Download in electronic PDF format for $75

Abstract:  The development and compounding of pharmacotherapeutic formulations that are suitable for infants and young children can be a challenging problem. This problem results from the lack of knowledge on the acceptability of different dosage forms and formulations to children in relation to age and developmental status, as well as the lack of reliable documentation of formulations used in pediatric clinical trials. As part of its mandate under the Best Pharmaceuticals for Children Act to improve pediatric therapeutics, the National Institute of Child Health and Human Development has sponsored the Pediatric Formulations Initiative. The goal of this ongoing initiative is to address the issues and concerns associated with pediatric therapeutics by convening groups of researchers and experts in pediatric formulations from academia, pharmaceutical companies, the National Institutes of Health, and the U.S. Food and Drug Administration. In this second part of a two-part article, the activities of the various groups that c

Related Keywords: George P. Giacoia, MD, Perdita Taylor-Zapata, MD, Donald Mattison, MD, children, pediatric formulations, oral dosage forms, NICHD, liquid formulations, Biopharmaceutical Classification System, patient compliance, flavoring, palatability, drug costs, drug taste, fast-dissolving preparations

Related Categories: LEGAL, PAIN MANAGEMENT, PEDIATRICS, PATIENT COMPLIANCE, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Developmentā€”Pediatric Formulations Initiative, Part 1
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 5-8

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
Sep/Oct 2006
Pg. 390

Prescription: Pediatric Formulation Initiatives
Allen Loyd V Jr
Nov/Dec 2005
Pg. 410

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
Jan/Feb 2001
Pg. 9-12

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George
, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010
Pg. 40-45

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Cho Sung Kyung
, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2020
Pg. 367-369

Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
Jul/Aug 1999
Pg. 274-276

Pediatric Dermatitis
Remmert Renee
Nov/Dec 2002
Pg. 419-421

Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
Nov/Dec 2005
Pg. 456-461

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Pediatric Oral Formulations: A Continual Challenge
Hurtado Josephine
, Moffett Brady S
Jan/Feb 2007
Pg. 17-19

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
Sep/Oct 2018
Pg. 358-366

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R
, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009
Pg. 14-18

Compounding for the Pediatric Patient
Allen Loyd V Jr
Mar/Apr 1997
Pg. 84-86

Pediatric Health Care: An Introduction
Williams LaVonn A
Jan/Feb 2013
Pg. 6-8

Return to Top